SomaLogic, Inc.
SomaLogic is a leader in high-plex proteomics, offering innovative solutions for biomarker discovery, disease research, and clinical applications. Their platform enables the measurement of thousands of proteins with high sensitivity, specificity, and reproducibility, supporting research across various therapeutic areas including cancer, cardiovascular disease, neurology, and more. The company is committed to advancing personalized medicine through its proprietary SOMAmer® reagents and comprehensive proteomic tools.
Industries
Nr. of Employees
large (251-1000)
SomaLogic, Inc.
2945 Wilderness Pl., Boulder, CO 80301
Patents
Products
High-plex aptamer-based proteomic assay (up to 11,000 targets)
A laboratory assay that uses chemically modified DNA aptamers to quantify up to thousands of protein analytes from small-volume biological samples for discovery and translational research.
High-plex aptamer-based proteomic assay (up to 11,000 targets)
A laboratory assay that uses chemically modified DNA aptamers to quantify up to thousands of protein analytes from small-volume biological samples for discovery and translational research.
Services
Processing of submitted human samples in an accredited laboratory with delivery of large-scale proteomic datasets for research studies.
Programs and technical support to enable partner laboratories to operate the assay locally, including workflow automation and technical training.
Online portal for study submission, progress tracking, result delivery, and direct interaction with a project manager and technical team.
Exploratory data analysis and visualization tools and services to merge datasets, perform statistical tests, and create interactive visualizations for proteomic studies.
High-parameter cytometry services to profile 40+ markers per sample using flow and imaging mass cytometry through a partnered discovery laboratory.
Sponsored grant program delivering assay processing and data for pilot sample sets through an authorized site partner to support preliminary research.
Processing of submitted human samples in an accredited laboratory with delivery of large-scale proteomic datasets for research studies.
Programs and technical support to enable partner laboratories to operate the assay locally, including workflow automation and technical training.
Online portal for study submission, progress tracking, result delivery, and direct interaction with a project manager and technical team.
Exploratory data analysis and visualization tools and services to merge datasets, perform statistical tests, and create interactive visualizations for proteomic studies.
High-parameter cytometry services to profile 40+ markers per sample using flow and imaging mass cytometry through a partnered discovery laboratory.
Sponsored grant program delivering assay processing and data for pilot sample sets through an authorized site partner to support preliminary research.
Expertise Areas
- High-plex proteomics
- Aptamer discovery and engineering
- Biomarker discovery and validation
- Proteogenomics and pQTL analysis
Key Technologies
- Aptamer-based high-plex proteomic assays
- SELEX and slow off-rate aptamer selection
- Base-modified oligonucleotide chemistry
- Multiplex DNA-based detection of protein binding
News & Updates
Learn about high-plex protein profiling at US HUPO 2024 in Portland, Oregon, including a booth and seminar.
Discover proteomics insights at AO HUPO 2023 in Singapore, including a booth and symposium.
Watch on-demand presentations from the Proteomics Day in Toulouse, France, covering various research topics.
Advancements in proteomic profiling reveal insights into obesity and metabolic health.
Proteomics-based approach to studying aging and health monitoring.
SomaLogic owns or controls over 600 issued patents and 300 pending applications, protecting its proprietary technologies.
Learn about high-plex protein profiling at US HUPO 2024 in Portland, Oregon, including a booth and seminar.
Discover proteomics insights at AO HUPO 2023 in Singapore, including a booth and symposium.
Watch on-demand presentations from the Proteomics Day in Toulouse, France, covering various research topics.
Advancements in proteomic profiling reveal insights into obesity and metabolic health.
Proteomics-based approach to studying aging and health monitoring.
SomaLogic owns or controls over 600 issued patents and 300 pending applications, protecting its proprietary technologies.